Skip to content

Clinical trials

Phase 1 Digestive System Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Digestive System Neoplasms Phase: Phase 1 Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20112
20122
20132
20142
20152
20162
20181
20193
20202
20212
20224
20236
20254
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Recruiting12
Terminated4
Unknown status4
Active, not recruiting2
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sichuan Baili Pharmaceutical Co., Ltd.7
Sir Run Run Shaw Hospital3
Revolution Medicines, Inc.2
Sumitomo Pharma America, Inc.2
Syndax Pharmaceuticals2
AVEO Pharmaceuticals, Inc.1
Beijing Immunochina Medical Science & Technology Co., Ltd.1
BioSyngen Pte Ltd1
CritiTech, Inc.1
Dongfang Hospital Beijing University of Chinese Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Digestive System Neoplasms40
Neoplasms9
Digestive System Diseases7
Neoplasms by Site7
Pancreatic Neoplasms6
Breast Neoplasms5
Colorectal Neoplasms5
Gastrointestinal Neoplasms5
Neoplasms, Glandular and Epithelial5
Respiratory Tract Neoplasms5

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.